Section(s) of the Registration Document • Amount of expenses and charges not deductible from taxable income N/A • Ages trial balance information for trade payables and receivables by maturity date Section 20.1 • Injunctions or fines for anticompetitive practices N/A • Agreements entered into between a director and/or officer or a shareholder holding more than N/A 10% of the voting rights and a subsidiary of the Company (excluding ordinary agreements) • Amount of inter-company loans Section 27 • Information on the operation of a SEVESO installation N/A 4.3. Information concerning officers • Summary of dealings in own shares of the Company by executives and related parties Section 14.1.5 4.4. CSR information of the Company • Consideration of the employment-related and environmental consequences of the business Sections 8.2 and 17.2 and social commitments in favor of sustainable development, preventing discrimination and promoting diversity 5. STATUTORY AUDITORS’ REPORT ON THE COMPANY’S ANNUAL FINANCIAL STATEMENTSSection 20.1.4 – FRENCH STANDARDS (FRENCH-GAAP) 6. STATUTORY AUDITORS’ REPORT ON THE COMPANY’S ANNUAL CONSOLIDATED Section 20.1.2 FINANCIAL STATEMENTS – INTERNATIONAL FINANCIAL REPORTING STANDARDS (IFRS) • Results of the last five financial years Annex I I • Aged Trade Payables Annex I I 7. BOARD’S REPORT ON CORPORATE GOVERNANCE 7.1. Information relating to remuneration • Principles and criteria for determining, distributing and allocating fixed, variable and exceptionalSection 15.1.1 items making up the total remuneration and benefits of any kind attributable to corporate officers as a result of the mandate • Compensation and benefits of any kind paid during the period to each executive officer by the Section 15.1.2 Company, companies that it controls and the company controlling it • Undertakings linked to assuming, terminating or changing functions N/A • In the case of stock option grants, reference to information according to which the Board of Directors took the decision to: – either prohibit executive managers from exercising their options prior to ceasing to exercise N/A their functions; – or to impose lockout obligations to registered holders until they cease to occupy their N/A functions on all or part of the shares resulting from options already exercised (by specifying accordingly the portion that was set) 7.2. Information concerning the composition, operation and powers of the Board • List of offices and responsibilities exercised in any company by each executive officer during theSections 14.1.1 and 14.1.2 year • Agreements concluded between a corporate officer or a shareholder holding more than 10% of N/A the voting rights and a subsidiary (excluding current agreements) • Summary of powers in progress granted by the General Meeting for capital increases Section 21.1.6 • Choice made on one of the two methods for exercising executive management in the event of a N/A modification • Composition, conditions of preparation and organization of the Board’s work Section 16 • Application of the principle of balanced representation of women and men on the Board Section 21.1.6 • Limitations of the powers of the general management Section 14.1.4 GENSIGHT BIOLOGICS – 2017 Registration Document – 3